Showing posts with label Infection. Show all posts
Showing posts with label Infection. Show all posts

Wednesday, June 16, 2010

World Cup horns could damage hearing, spread infectious diseases.

Moral of the story: wear earplugs and wash your hands.

Source: AMA Morning Rounds 6/16/2010

World Cup horns could damage hearing, spread infectious diseases.


The Wall Street Journal (6/15, Stewart) reported that instead of the enthusiastic chants and cheers which usually play background to the World Cup, fans are hearing something quite different: loud plastic horns known as vuvuzelas. Traditionally, they were used to rally people living in remote places. Today, however, they are being used to champion athletes. But, in addition to the conflict they're causing among attendees and broadcasters, health experts are now saying they prompt hearing loss. In fact, researchers have found that even in the presence of hearing protection, the sound is "unacceptably high," louder even than an air horn and chain saw. The horn's biggest threat, however, is its ability to spread infectious disease like the flu.

Sunday, March 21, 2010

Staples lead to higher risk of infection after joint surgery than traditional stitches

Moral of the story: with JOINT surgery staples are a BAD idea. Ask for traditional stitches (they take longer but decrease your risk of infection)

(1) Staples lead to higher risk of infection after joint surgery than traditional stitches
(Research: Sutures versus staples for skin closure in orthopaedic surgery: meta-analysis)
http://www.bmj.com/cgi/content/full/340/mar16_1/c1199 (Editorial: Staples for skin closure in surgery)
http://www.bmj.com/cgi/content/full/340/mar16_1/c403
Using metal staples to close wounds after orthopaedic (joint) surgery can lead to a greater risk of infection than using traditional nylon sutures, concludes a study published on bmj.com today.
Orthopaedic surgeons are therefore advised to reconsider their use of staples to close wounds after hip or knee surgery while further trials are carried out to confirm these findings.
Wound complications are one of the major sources of illness following orthopaedic procedures like knee and hip surgery. They can prolong a patient's stay in hospital or lead to re-admission. There is also a link between superficial wound infection and deep infection.
Orthopaedic surgeons use both metallic staples and nylon sutures to close wounds. Staples are regarded as quicker and easier than sutures, but some have suggested that staples are more likely to cause infection and may also be more expensive.
The optimal method of skin closure still remains unclear, so researchers at Norfolk and Norwich University Hospital analysed the results of six trials that compared the use of staples to sutures following orthopaedic procedures in adults.
The trials involved 683 wounds; 322 patients underwent suture closure and 351 staple closure. Overall, the risk of developing a superficial wound infection was over three times greater after staple closure than suture closure.
For hip surgery only, the risk of developing a wound infection was four times greater after staple closure than suture closure. There was no significant difference between sutures and staples in the development of inflammation, discharge, dehiscence (re-opening of a previously closed wound), necrosis and allergic reaction.
The authors point out that the quality of evidence was generally poor and they call for high quality, well designed trials to confirm their findings. However, based on the current evidence, they suggest that patients and doctors should think more carefully about the use of staples for wound closure after hip and knee surgery.
These results fit with evidence from other specialties, says Consultant Orthopaedic Surgeon, Bijayendra Singh, in an accompanying editorial. He points out that the most consistent benefit of staples is more rapid skin closure, yet the time saved is rarely more than two to three minutes. The saving may also be reduced by the increased costs of removing the staples (compared with absorbable stitches) and reduced even further by the costs of treating the increased number of infections.
Contacts:
Research: Toby Smith, Research Physiotherapist in Orthopaedics, Honorary Lecturer, Norfolk and Norwich University Hospital, Norwich, UK
Email: toby.smith@nnuh.nhs.uk Editorial: Bijayendra Singh, Consultant Orthopaedic Surgeon, Medway Foundation NHS Trust, Gillingham, UK
Email: bisortho@doctors.org.uk

Sunday, November 29, 2009

One in four teenage girls may test positive for an STD.

Moral of the story: STDs are still very prevalent

Source: AMA Morning Rounds 11/24/09

One in four teenage girls may test positive for an STD.

HealthDay (11/23, Reinberg) reported, "As many as one in four US teenage girls have had a sexually transmitted disease (STD)," according to a CDC study published in Pediatrics. Investigators tested "838 teen girls aged 14 to 19" for "Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, herpes simplex virus type 2, and human papillomavirus (HPV)." They eventually discovered that "24.1 percent of the girls had one of these STDs, and among girls who were sexually experienced, 37.7 percent had an STD. HPV was the most common infection (18.3 percent), followed by chlamydia (3.9 percent)."

The "most concerning" aspect of the findings, however, was "how soon these sexually transmitted infections appeared after teenage girls began engaging in sexual activity," according to WebMD (11/23, Warner). "The study showed that within one year of initiating sexual activity, 19.2% of teen girls had an STI."

Friday, October 30, 2009

Study suggests statins may help prevent deaths from seasonal flu.

Moral of the story: Again, just like with pneumonia, if you are already taking statins you are likely to be able to better fight off the flu (not swine flu). Not that you should start taking statins to fight off pneumonia or the flu, but a statin regimen will help. If you want to be proactive about fighting off the flu, get a flu shot.

Source: AMA Morning Rounds 10/30/09

The AP (10/30, Marchione) reports that individuals already taking statins "when they caught seasonal flu and had to be hospitalized were twice as likely to survive than those who were not on such medicines," according to a study presented at an Infectious Diseases Society of America conference. Investigators looked at data on "2,800 people hospitalized with lab-confirmed seasonal flu in 10 states in 2007-2008." While "more than three percent of those not taking statins died in the hospital or in the following month," the researchers found that "the rate was half that among statin users, even though they were more likely to have underlying health problems like heart disease."

Reuters (10/30, Fox) quotes one of the study's researchers as saying, "This early research suggests there may be a role for statins in influenza treatment and it should be studied further."

WebMD (10/29, Laino) reported that the researchers "are now analyzing the data to determine if one brand of statin is associated with better odds of surviving the flu than another." HealthDay (10/29, Reinberg) also covered the story.

Wednesday, February 25, 2009

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

Moral of the story: There may be a cure for HIV infection, and we may find it soon. This person was cured of HIV thanks to a bone marrow transplantation (he had leukemia) that inserted a certain type of stem cell into his body that did not allow for HIV infection of the immune system. Incredible. Notice they are much more cautious than I and have called it long-term control. Any way you cut it, this is huge.

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Gero Hütter, M.D., Daniel Nowak, M.D., Maximilian Mossner, B.S., Susanne Ganepola, M.D., Arne Müßig, M.D., Kristina Allers, Ph.D., Thomas Schneider, M.D., Ph.D., Jörg Hofmann, Ph.D., Claudia Kücherer, M.D., Olga Blau, M.D., Igor W. Blau, M.D., Wolf K. Hofmann, M.D., and Eckhard Thiel, M.D.
SUMMARY
Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5). Homozygosity for a 32-bp deletion in the CCR5 allele provides resistance against HIV-1 acquisition. We transplanted stem cells from a donor who was homozygous for CCR5 delta32 in a patient with acute myeloid leukemia and HIV-1 infection. The patient remained without viral rebound 20 months after transplantation and discontinuation of antiretroviral therapy. This outcome demonstrates the critical role CCR5 plays in maintaining HIV-1 infection.

Monday, February 9, 2009

CDC Confirms First Case Of Marburg Fever In Colorado

Moral of the story: none, unless you are going to Uganda and going to be near fruit bats, then you had better be careful, very very careful.

CDC Confirms First Case Of Marburg Fever In Colorado Featured ArticleMain Category: Infectious Diseases / Bacteria / VirusesArticle Date: 09 Feb 2009

After repeat testing, the US Centers for Disease Control and Prevention (CDC) confirmed at the end of last month that a man treated last year in a Colorado hospital had contracted Marburg hemorrhagic fever, the first known case in the United States.According to a report in the online version of Colorado's daily newspaper Rocky Mountain News late on Friday, the man contracted the virus during a visit to Uganda and was treated at Lutheran Medical Center in Wheat Ridge in January 2008. The man recovered and came back for a follow up in June 2008 when he was re-tested.The man, who has not been identified, had visited a python cave in Maramagambo Forest in Queen Elizabeth Park in Uganda. The cave is populated by fruit bats, known to carry the Marburg virus.According to the CDC, Marburg hemorrhagic fever is a rare, severe type of animal-borne hemorrhagic fever that affects both humans and non-human primates.It is caused by a unique member of the filovirus family, of which the five species of Ebola are the only other known members. While the virus is indigenous to Africa, it carries the name Marburg because it was first recognized in 1967 when outbreaks of the fever simultaneously broke out in laboratories in Marburg and Frankfurt in Germany and in Belgrade, in what was then Yugoslavia (now Serbia). The outbreaks killed 37 people in all, some were lab workers and some were family members who had nursed them. The lab workers had caught the virus from African green monkeys that had been imported for research on polio vaccine.Lutheran Medical Center is working with state and local health authorities and the CDC to establish the risk doctors and staff have been exposed to as a result of coming into contact with the patient.A spokeswoman for Exempla Healthcare, of which the Lutheran Medical Centre is a part, told Rocky Mountain News that so far investigations have concluded that none of the doctors and staff who cared for the patient have developed symptoms of the fever. However, any member of staff who is still concerned can still get a blood test, said the paper.Exactly how the virus is transmitted is not known, says the CDC, but the incubation period is about 5 to 10 days and the onset of the disease is quite sudden, with fever, chills, headache, and myalgia (muscle pain). It is most likely passed via bodily fluids, such as blood drops, and doctors and care staff should wear protective gowns, gloves and masks around the patient.About 5 days after the symptoms start, the patient may get a maculopapular rash of spots and bumps, most noticeable on the chest, back and stomach. This may then be followed by nausea, vomiting, chest pain, sore throat, abdominal pain, and diarrhea. Symptoms then become more and more severe, and may include jaundice, inflammation of the pancreas, delirium, shock, severe weight loss, liver failure, and multiple organ dysfunction. The disease can be fatal.Diagnosis of Marburg fever is made difficult by the fact the symptoms are similar to those of other infectious diseases, such as malaria or typhoid fever, says the CDC, which may explain why it wasn't diagnosed at the time, but there was no explanation as to why the first lab test didn't identify it.Officials from the hospital told Rocky Mountain News that they followed the protocols for dealing with an unknown infection. This included:"Contact isolation (gown and glove) and testing for a number of infectious [agents], with some of the tests being performed at the CDC."Click here for more information on Marburg fever (CDC).Sources: Rocky Mountain News, CDC.Written by: Catharine Paddock, PhD Copyright: Medical News Today

Friday, January 23, 2009

Philippines pig farm worker infected with Ebola-Reston

Moral of the story: This is some nasty stuff, good thing it never spread out of Reston, VA when it was in the states. The return of this thing is scary, it can travel extremely quickly across the entire globe. I wouldn't be surprised if this pops up again fairly soon somewhere else.

Philippines pig farm worker infected with Ebola strain: WHO

By AFP - Fri Jan 23, 1:00 AM PST
MANILA (AFP) - A Philippine pig farm worker has tested positive for the Ebola-Reston virus, according to Health Secretary Francisco Duque and the World Health Organisation (WHO).


Piglets are seen at a small family farm outside the quarantined commercial pig farm infected with Ebola-Reston virus in Pandi town north of Manila on January 8. Philippine pig farm worker has tested positive for the Ebola-Reston virus, Health Secretary Francisco Duque and the WHO said Friday.(AFP/File/Romeo Gacad)
The strain is different from the Ebola sub-types found in Africa that cause deadly haemorrhagic fever in humans.
Duque told a news conference that the farm worker's blood carried the virus's anti-bodies.
"Otherwise, he is healthy and has no sign of any sickness," he said.
The identity and age of the infected worker and the location of the farm was not disclosed.
Duque said health authorities were still trying to find out how the farmer got the virus.
He said they were not prepared to say if the farm worker was infected by pigs.
The announcement came at the end of a WHO-led mission to the Philippines that investigated the viral outbreak on pig farms last year.
The government earlier quarantined several farms in the northern Philippine towns of Pandi and Talavera after the Ebola-Reston virus was discovered there.
This Ebola strain, which is found only in the Philippines, had been confined to monkeys. But the latest outbreak among pigs was the first time it has jumped species, and later infected humans.
Duque also clarified that only four pigs had tested positive for the virus among about 6,000 tested by authorities between July and September 2008.
Ebola-Reston was first detected in 1989 in laboratory monkeys sent from the Philippines to Reston, Virginia, in the United States.

Wednesday, January 21, 2009

Salmonella Typhimurium Outbreak in Peanut Butter

Moral of the Story: Don't eat peanut butter!

Salmonella Typhimurium Outbreak
Update on FDA's Investigation
January 19, 2009: The Food and Drug Administration (FDA) is conducting a very active and dynamic investigation into the source of the Salmonella Typhimurium outbreak. At this time, the FDA, the Centers for Disease Control and Prevention (CDC), and state partners have traced sources of Salmonella Typhimurium contamination to a plant owned by Peanut Corporation of America (PCA), which manufactures peanut butter and peanut paste—a concentrated product consisting of ground, roasted peanuts—that are both distributed to food manufacturers to be used as an ingredient in many commercially produced products including cakes, cookies, crackers, candies, cereal and ice cream. In addition, PCA peanut butter is distributed to and institutionally served in such settings as long-term care facilities and cafeterias.
The FDA has notified PCA that product samples originating from its Blakely, Georgia (Ga.), processing plant have been tested and found positive for Salmonella by laboratories in the states of Minnesota and Connecticut. Connecticut and Minnesota have reported to FDA that samples of King Nut peanut butter tested in those states are a genetic match to the strain of Salmonella associated with the nationwide outbreak of Salmonella Typhimurium. The results from the Connecticut Department of Health Laboratory are from an unopened container of King Nut peanut butter. FDA wishes to acknowledge the Connecticut laboratory, Infectious Disease Section and Department of Consumer Protection as well as health officials in Minnesota for their efforts. King Nut is a distributor of PCA product. This information, along with the results available from laboratory testing and the CDC epidemiological analysis, have now led FDA to confirm that the source of this outbreak is peanut butter and peanut paste produced by PCA at its Blakely, Ga. processing plant.
On January 18, PCA expanded its previous voluntary recall to include more products and lot numbers relating to peanut butter and peanut paste products manufactured on or after July 1, 2008, at its Blakely, Ga., plant because of potential Salmonella contamination. The peanut butter products being recalled are sold by PCA in bulk containers ranging in size from five (5) to 1700 pounds. The peanut paste is sold in sizes ranging from 35-pound containers to product sold by the tanker container. These products are not sold directly to consumers. PCA has stopped all production at its Blakely, Ga. plant as the FDA continues its investigation. Based on this information, and on the current state of the investigation, the FDA recommends that consumers avoid eating products that have been recalled and discard them.
Major national brands of jarred peanut butter are not affected by the PCA recall. PCA does not sell peanut butter directly to consumers. PCA only sells peanut butter to institutions and food manufacturers (some of which use it as an ingredient in other processed/packaged foods). Some food manufacturers use PCA peanut butter or peanut paste in baked or processed foods, such as crackers, cookies, cakes or ice cream to name a few. The FDA and food manufacturers are working to identify products that may be affected, and to track the ingredient supply chain of those products to facilitate their removal from the marketplace.
Based on available information, FDA and CDC recommendations include:
For Consumers
FDA has created a searchable list of products and brands associated with the expanded PCA recall. This list is available on the FDA website at:http://www.accessdata.fda.gov/scripts/peanutbutterrecall/index.cfm and will be updated on a regular basis as additional sub recalls occur and information is received by FDA from the industry.
Because identification of products subject to recall is continuing, the FDA urges consumers to first visit FDA’s website to determine if commercially-prepared or manufactured peanut butter/peanut paste-containing products (such as cookies, crackers, cereal, candy and ice cream) are subject to recall. If consumers do not find the product of interest on FDA’s website they may wish to call the toll-free number listed on most food packaging or visit the company’s website.
If consumers cannot determine if their peanut butter, peanut butter/peanut paste-containing products or institutionally-served peanut butter may contain PCA peanut butter/peanut paste, we recommend that they do not consume those products. Efforts to specifically identify products subject to the PCA recall and to continuously update consumers are ongoing.
Do not eat products that have been recalled and throw them away in a manner that prevents others from eating them.
Persons who think they may have become ill from eating peanut butter are advised to consult their health care providers.